BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20473008)

  • 1. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
    Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of admission haematological indices with infarct-related artery patency in patients with acute ST-segment elevation myocardial infarction treated with primary angioplasty.
    Maden O; Kacmaz F; Selcuk MT; Selcuk H; Metin F; Tufekcioglu O; Atak R; Balbay Y; Ilkay E
    Coron Artery Dis; 2007 Dec; 18(8):639-44. PubMed ID: 18004115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of admission mean platelet volume on TIMI frame count measured after fibrinolytic therapy in patients with acute ST-segment elevation myocardial infarction].
    Celebi OO; Canbay A; Celebi S; Sahin D; Aydoğdu S; Diker E
    Turk Kardiyol Dern Ars; 2009 Jul; 37(5):307-11. PubMed ID: 19875902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy.
    Amos DJ; French JK; Andrews J; Ashton NG; Williams BF; Whitlock RM; Manda SO; White HD
    Am Heart J; 2001 Apr; 141(4):586-91. PubMed ID: 11275924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between infarct-related coronary artery patency and predischarge electrocardiographic patterns in patients with first anterior myocardial infarction who received thrombolytic therapy.
    Atak R; Ileri M; Senen K; Turhan H; Erbay AR; Basar N; Yetkin E; Demirkan D
    Heart Vessels; 2004 Mar; 19(2):63-7. PubMed ID: 15042389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris.
    Duygu H; Turkoglu C; Kirilmaz B; Turk U
    J Invasive Cardiol; 2008 Mar; 20(3):120-4. PubMed ID: 18316827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
    Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
    Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Estévez-Loureiro R; Salgado-Fernández J; Marzoa-Rivas R; Barge-Caballero E; Pérez-Pérez A; Noriega-Concepción V; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A; Kaski JC
    Thromb Res; 2009 Nov; 124(5):536-40. PubMed ID: 19467699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.
    Valenzuela LF; Vázquez R; Fournier JA; Cubero J; Maraví J; Cruz-Fernández JM; Kaski JC
    Int J Cardiol; 2007 Feb; 115(3):381-5. PubMed ID: 16814417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.
    Ozkan B; Cagliyan CE; Elbasan Z; Uysal OK; Kalkan GY; Bozkurt M; Tekin K; Bozdogan ST; Ozalp O; Duran M; Sahin DY; Cayli M
    Coron Artery Dis; 2012 Sep; 23(6):400-3. PubMed ID: 22850480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct].
    Bruna C; Vado A; Rossetti G; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Uslenghi E
    G Ital Cardiol; 1997 Nov; 27(11):1144-52. PubMed ID: 9463058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction.
    Fernandez AR; Sequeira RF; Chakko S; Correa LF; de Marchena EJ; Chahine RA; Franceour DA; Myerburg RJ
    J Am Coll Cardiol; 1995 Sep; 26(3):675-83. PubMed ID: 7642858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indirect criteria of coronary reperfusion and permeability in patients with acute myocardial infarction who have received thrombolytic therapy].
    Pereira MA; Albuquerque A; Azevedo JG; Torres S; Gomes L; Campos M; Pimenta A
    Rev Port Cardiol; 1991 Mar; 10(3):229-35. PubMed ID: 1854515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
    Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.
    Greenbaum AB; Ohman EM; Gibson CM; Borzak S; Stebbins AL; Lu M; Le May MR; Stankowski JE; Emanuelsson H; Weaver WD
    Am Heart J; 2007 Oct; 154(4):702-9. PubMed ID: 17892995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.